Literature DB >> 3005621

New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products.

A J Davison, C M Edson, R W Ellis, B Forghani, D Gilden, C Grose, P M Keller, A Vafai, Z Wroblewska, K Yamanishi.   

Abstract

The accumulation of recent data concerning the reactivity of monoclonal antibodies with particular varicella-zoster virus (VZV) glycoproteins and the mapping of several of their respective genes on the VZV genome has led to a unified nomenclature for the glycoprotein genes of VZV and their mature glycosylated products. Homologs to herpes simplex virus glycoprotein genes are noted.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3005621      PMCID： PMC252860     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  18 in total

1.  Varicella-zoster viral glycoproteins analyzed with monoclonal antibodies.

Authors:  B Forghani; K W Dupuis; N J Schmidt
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

2.  Analysis of three late varicella-zoster virus proteins, a 125,000-molecular-weight protein and gp1 and gp3.

Authors:  A Vafai; Z Wroblewska; M Wellish; M Green; D Gilden
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

3.  Serological reactivity of some monoclonal antibodies to varicella-zoster virus.

Authors:  B Forghani; N J Schmidt; C K Myoraku; D Gallo
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

4.  Use of a bacterial expression vector to map the varicella-zoster virus major glycoprotein gene, gC.

Authors:  R W Ellis; P M Keller; R S Lowe; R A Zivin
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

5.  Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties.

Authors:  E A Montalvo; R T Parmley; C Grose
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

6.  Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein.

Authors:  C Grose; D P Edwards; K A Weigle; W E Friedrichs; W L McGuire
Journal:  Virology       Date:  1984-01-15       Impact factor: 3.616

7.  Glycoprotein gp118 of varicella-zoster virus: purification by serial affinity chromatography.

Authors:  W E Friedrichs; C Grose
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  Monoclonal antibodies against three major glycoproteins of varicella-zoster virus.

Authors:  C Grose; D P Edwards; W E Friedrichs; K A Weigle; W L McGuire
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

9.  Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles.

Authors:  K A Weigle; C Grose
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

10.  Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes.

Authors:  P M Keller; B J Neff; R W Ellis
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103
View more
  28 in total

1.  Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections.

Authors:  K Baba; K Shiraki; T Kanesaki; K Yamanishi; P L Ogra; H Yabuuchi; M Takahashi
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

2.  Bovine herpesvirus type 1 gp87 mediates both attachment of virions to susceptible cells and hemagglutination.

Authors:  K Okazaki; E Honda; T Minetoma; T Kumagai
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  A tyrosine-based motif and a casein kinase II phosphorylation site regulate the intracellular trafficking of the varicella-zoster virus glycoprotein I, a protein localized in the trans-Golgi network.

Authors:  A Alconada; U Bauer; B Hoflack
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

4.  Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration.

Authors:  A O Fuller; R E Santos; P G Spear
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

5.  Effect of brefeldin A on alphaherpesvirus membrane protein glycosylation and virus egress.

Authors:  M E Whealy; J P Card; R P Meade; A K Robbins; L W Enquist
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

6.  Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.

Authors:  M Takayama
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

7.  Unusual phosphorylation sequence in the gpIV (gI) component of the varicella-zoster virus gpI-gpIV glycoprotein complex (VZV gE-gI complex).

Authors:  Z Yao; C Grose
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  A systematic approach for the identification of novel, serologically reactive recombinant Varicella-Zoster Virus (VZV) antigens.

Authors:  Maria G Vizoso Pinto; Klaus-Ingmar Pfrepper; Tobias Janke; Christina Noelting; Michaela Sander; Angelika Lueking; Juergen Haas; Hans Nitschko; Gundula Jaeger; Armin Baiker
Journal:  Virol J       Date:  2010-07-20       Impact factor: 4.099

9.  Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype.

Authors:  Charles Grose; Shaun Tyler; Geoff Peters; Joanne Hiebert; Gwen M Stephens; William T Ruyechan; Wallen Jackson; Johnathan Storlie; Graham A Tipples
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network.

Authors:  A A Gershon; D L Sherman; Z Zhu; C A Gabel; R T Ambron; M D Gershon
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.